A study in mice showed how T2D drug metformin exerts multiple clinical effects through selective inhibition of mitochondrial ...

For the second year in a row, GEN spoke with David Barrett, JD, who has been the CEO of ASGCT since 2016. In this interview, we discuss his perspective on the event, if there is anything new that ...

At ASGCT, the company will share data showing that its RNA achieves higher, more durable protein expression compared to other ...

The FDA has granted accelerated approval to Regeneron Pharmaceuticals’ Otarmeni™ (lunsotogene parvec-cwha) as the first gene ...

Enein, MD, PhD, for a measurement-driven approach that advances cell therapy translation, from high-dimensional analytics to ...

Macrophages use cell‑volume changes to sense danger, reprogram gene expression, and heighten inflammatory and antiviral responses.

Researchers say identified mAbs could represent “a basis to develop a treatment that is urgently needed as measles virus ...

The data shows that the drugs triggered activity in the central amygdala that reduced dopamine release into the brain's reward circuitry.

There has been widespread success in treating blood cancers, while progress in solid tumors has been more limited.

In this GEN webinar, Joseph Shultz (VP of technical development and manufacturing, Ottimo Pharma) and Imroz Ghangas (VP of commercial sales, Asimov) discuss strategies for achieving high-performing ...

In this GEN webinar, Alex Zevin, PhD, director of Fred Hutchinson Cancer Center’s Genomics Shared Resource, draws on hands-on ...

Last month, the AGBT Agricultural Meeting was held in Phoenix, Arizona. The conference is focused on agricultural ...